L. Becker Hewes - 06 Jun 2022 Form 4 Insider Report for Blueprint Medicines Corp (BPMC)

Signature
/s/ Ariel Hurley, Attorney-in-Fact
Issuer symbol
BPMC
Transactions as of
06 Jun 2022
Net transactions value
-$262,207
Form type
4
Filing time
08 Jun 2022, 16:05:12 UTC
Previous filing
18 Mar 2022
Next filing
03 Mar 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BPMC Common Stock Sale $72,907 -1,220 -3.9% $59.76 30,451 06 Jun 2022 Direct F1
transaction BPMC Common Stock Sale $189,300 -3,155 -10% $60.00 27,296 07 Jun 2022 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.
F2 Effected pursuant to a trading plan adopted on August 13, 2021 pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.